Walleye Capital’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Walleye Capital's EWTX Position: Q3 2026 in Review
Walleye Capital opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 9,125 shares worth $370K. The stake represents ﹤0.01% of the portfolio and ranks #4331 among its holdings. This is a return to the name: Walleye Capital previously reported a position in EWTX as recently as Q2 2025.
Walleye Capital first reported a position in EWTX in Q1 2022 and has held it in 7 quarters since. The position peaked at $6.47M in Q3 2024. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Walleye Capital held 9,125 shares of Edgewise Therapeutics worth $370K as of Q3 2026.
- Edgewise Therapeutics was a new Walleye Capital position in Q3 2026.
- Edgewise Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4331 holding.
- Walleye Capital first reported a position in Edgewise Therapeutics in Q1 2022 and has held it in 7 quarters since.
- Walleye Capital's Edgewise Therapeutics position peaked at $6.47M in Q3 2024.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.